Real-world Treatment Patterns and Outcomes in Stage III Non-small Cell Lung Cancer: Middle East and Africa – KINDLE Study
- 11 February 2022
- journal article
- research article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 23 (4) , 364-373
Abstract
No abstract availableKeywords
Funding Information
- Bristol-Myers Squibb
- AstraZeneca
This publication has 28 references indexed in Scilit:
- Multidisciplinary team management in thoracic oncology: more than just a concept?European Respiratory Journal, 2014
- Multidisciplinary care team for cancer patients and its implementation in several Middle Eastern countriesAnnals of Oncology, 2013
- Smoking habits in the Middle East and North Africa: Results of the BREATHE studyRespiratory Medicine, 2012
- Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410JNCI: Journal of the National Cancer Institute, 2011
- Population-Based Estimates of Survival Benefit Associated with Combined Modality Therapy in Elderly Patients with Locally Advanced Non-small Cell Lung CancerJournal of Thoracic Oncology, 2011
- Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine, 2009
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)Epidemiology, 2007
- Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 TrialJNCI: Journal of the National Cancer Institute, 1996